GlassScriptPhysician profile
Rashesh Shah
NPI 1376999367
$13,319.86
in general payments reported to CMS, 2019-2025
25 companies · $3,495 in 2025
The $3,495 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $272 · 2021: $410 · 2022: $4,673 · 2023: $2,902 · 2024: $1,133 · 2025: $3,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,515 · Travel and Lodging: $2,015 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,514.57 |
| Travel and Lodging | $2,015.03 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,774.13 | 2019-2025 | Navitor, Mitraclip |
| Medtronic, INC. | $2,345.54 | 2022-2025 | Corevalve Evolut R, Onyx Frontier, Hawkone |
| Atricure, INC. | $2,180.08 | 2022-2023 | |
| Edwards Lifesciences Corporation | $1,010.64 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $797.05 | 2019-2025 | Mamba, Synergy, Wolverine Coronary Cutting Balloon |
| Abiomed | $749.78 | 2024-2025 | Impella |
| Shockwave Medical, INC | $586.94 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $413.65 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $377.86 | 2021-2025 | Wainua, Farxiga |
| Cardiovascular Systems INC. | $369.12 | 2022-2023 | Diamondback Peripheral |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $339.41 | 2022-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $324.50 | 2022-2025 | Assure Wcd |
| Pfizer INC. | $230.12 | 2019-2022 | |
| Astellas Pharma US INC | $178.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $163.40 | 2021-2024 | Camzyos |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $100.21 | 2022 | |
| Teleflex LLC | $98.03 | 2023 | Guideliner |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $51.86 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $50.38 | 2022-2023 | Gore Cardioform Septal Occluder |
| Stryker Corporation | $37.69 | 2021 | |
| Terumo Medical Corporation | $18.76 | 2023 | Glidewire |
| Actelion Pharmaceuticals US, INC. | $14.66 | 2021 | |
| Amgen INC. | $14.54 | 2020 | |
| Glaxosmithkline, LLC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashesh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.